A PHASE 1/2 OPEN-LABEL ROLLOVER STUDY FOR SUBJECTS WHO HAVE PARTICIPATED IN AN ASTELLAS SPONSORED ASP2215 TRIAL

Protocol: 
AAAR5065
Phase: 
I/II

A PHASE 1/2 OPEN-LABEL ROLLOVER STUDY FOR SUBJECTS WHO HAVE PARTICIPATED IN AN ASTELLAS SPONSORED ASP2215 TRIAL

Are you Eligible? (Inclusion Criteria)

1) Age >= 18 years
2) Currently receiving ASP2215 in an Astellas sponsored ASP2215 trial
3) Patient must be deriving benefit from continued treatment of ASP2215, as determined by the doctor

Specialty Area(s)

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States